Romania fines GSK for breaching commitments
Romania’s Competition Council has fined GlaxoSmithKline €2.4 million for failing to comply with commitments it imposed in 2017, which required the pharmaceutical company to continue supplying three asthma drugs nationally.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.